Current Report Filing (8-k)
July 14 2017 - 1:49PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 14, 2017
Graham Corporation
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
1-8462
|
|
16-1194720
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
20 Florence Avenue, Batavia, New York
|
|
14020
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (585)
343-2216
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the
filing obligation of the Registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or
Rule 12b-2 of
the Securities Exchange Act of
1934 (§240.12b-2 of
this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
In the proxy statement of Graham Corporation (the Company) dated
June 22, 2017, the Company disclosed that during fiscal year 2017, one director, Gerard T. Mazurkiewicz, failed to attend at least 75% of the aggregate of (1) the total number of meetings of the Companys Board of Directors (the
Board) and (2) the total number of meetings of all committees of the Board on which he served. This was the result of Mr. Mazurkiewicz being unable to attend a single day of Board and committee meetings due to illness, causing
him to miss the Board meeting and the meetings of the Audit Committee and the Nominating & Corporate Governance Committee that were held on that day. Except for this absence on a single day of meetings, Mr. Mazurkiewicz attended 100%
of the meetings of the Board and the committees on which he served during fiscal year 2017.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
Graham Corporation
|
|
|
|
|
Date: July 14, 2017
|
|
|
|
By:
|
|
/s/ Jeffrey Glajch
|
|
|
|
|
|
|
Jeffrey Glajch
|
|
|
|
|
|
|
Vice President Finance & Administration and
|
|
|
|
|
|
|
Chief Financial Officer
|
Graham (NYSE:GHM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Graham (NYSE:GHM)
Historical Stock Chart
From Jul 2023 to Jul 2024